1. Home
  2. PHVS vs ALGT Comparison

PHVS vs ALGT Comparison

Compare PHVS & ALGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • ALGT
  • Stock Information
  • Founded
  • PHVS 2015
  • ALGT 1997
  • Country
  • PHVS Switzerland
  • ALGT United States
  • Employees
  • PHVS N/A
  • ALGT N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • ALGT Air Freight/Delivery Services
  • Sector
  • PHVS Health Care
  • ALGT Consumer Discretionary
  • Exchange
  • PHVS Nasdaq
  • ALGT Nasdaq
  • Market Cap
  • PHVS 980.3M
  • ALGT 750.0M
  • IPO Year
  • PHVS 2021
  • ALGT 2006
  • Fundamental
  • Price
  • PHVS $18.60
  • ALGT $60.29
  • Analyst Decision
  • PHVS Buy
  • ALGT Hold
  • Analyst Count
  • PHVS 6
  • ALGT 10
  • Target Price
  • PHVS $37.17
  • ALGT $66.70
  • AVG Volume (30 Days)
  • PHVS 35.9K
  • ALGT 373.7K
  • Earning Date
  • PHVS 08-13-2025
  • ALGT 07-30-2025
  • Dividend Yield
  • PHVS N/A
  • ALGT N/A
  • EPS Growth
  • PHVS N/A
  • ALGT N/A
  • EPS
  • PHVS N/A
  • ALGT N/A
  • Revenue
  • PHVS N/A
  • ALGT $2,555,257,000.00
  • Revenue This Year
  • PHVS N/A
  • ALGT $8.29
  • Revenue Next Year
  • PHVS N/A
  • ALGT $10.80
  • P/E Ratio
  • PHVS N/A
  • ALGT N/A
  • Revenue Growth
  • PHVS N/A
  • ALGT 1.54
  • 52 Week Low
  • PHVS $11.51
  • ALGT $36.09
  • 52 Week High
  • PHVS $25.50
  • ALGT $107.57
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 60.00
  • ALGT 63.65
  • Support Level
  • PHVS $16.72
  • ALGT $54.46
  • Resistance Level
  • PHVS $17.53
  • ALGT $59.93
  • Average True Range (ATR)
  • PHVS 0.93
  • ALGT 2.35
  • MACD
  • PHVS 0.07
  • ALGT 0.70
  • Stochastic Oscillator
  • PHVS 92.86
  • ALGT 99.46

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

About ALGT Allegiant Travel Company

Allegiant Travel Co is a leisure travel company focused on providing travel and leisure services and products to residents of under-served cities in the United States. It operates a low-cost, low utilization passenger airline marketed to leisure travelers in under-served cities, allowing it to sell air transportation both on a stand-alone basis and bundled with the sale of air-related and third-party services and products. In addition, it provides air transportation under fixed-fee flight arrangements. In connection with its leisure travel focus, the company has opened Sunseeker Resort Charlotte Harbor, equipped with several guestrooms and food and beverage outlets. The company's operating segments are the Airline, which generates maximum revenue, and Sunseeker Resort.

Share on Social Networks: